Profilin1 is required for prevention of mitotic catastrophe in murine and human glomerular diseases

Xuefei Tian1, Christopher E Pedigo1, Ke Li2

  • 1Section of Nephrology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.

Insights

Profilin1 (Pfn1) is crucial for maintaining podocyte health and kidney function. Its loss causes mitotic catastrophe, leading to severe kidney disease.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Proteinuric kidney diseases involve podocyte loss, but mechanisms are unclear.
  • Podocytes attempt DNA repair by reentering the cell cycle, but errors cause cell death.
  • Mitotic catastrophe (MC) is a potential mechanism for podocyte loss in kidney disease.

Purpose of the Study:

  • Investigate the role of Pfn1 in maintaining podocyte integrity.
  • Determine if Pfn1 deficiency causes podocyte MC and kidney disease.
  • Explore PFN1's role in human proteinuric kidney diseases.

Main Methods:

  • Generated podocyte-specific Pfn1 knockout (KO) mice.
  • Utilized FUCCI2aR mice to track podocyte cell cycle reentry.
  • Performed RNA-Seq and ribosome profiling in Pfn1-KO podocytes.
  • Analyzed kidney tissues from patients with proteinuric kidney diseases.

Main Results:

  • Podocyte-specific Pfn1 loss caused severe proteinuria and kidney failure in mice.
  • Histological and ultrastructural analysis revealed podocyte MC.
  • Observed altered cell cycle protein expression (p21, p53, cyclin B1, cyclin D1).
  • Downregulation of ribosomal RNA-processing 8 (Rrp8) was identified in Pfn1-KO podocytes.
  • Overexpressing Rrp8 partially rescued Pfn1-KO podocyte phenotype in vitro.
  • Confirmed MC podocytes and reduced PFN1 expression in human kidney disease tissues.

Conclusions:

  • Profilin1 (Pfn1) is essential for regulating the podocyte cell cycle.
  • Disruption of Pfn1 leads to podocyte mitotic catastrophe (MC).
  • Pfn1 deficiency and MC contribute to podocyte loss and kidney disease progression.
  • PFN1 may be a therapeutic target for proteinuric kidney diseases.